# 25% Dextrose Infant

NDC: 51662-1213
Generic name: 25% Dextrose Infant
Labeler / Manufacturer: HF Acquisition Co. LLC, DBA Health First
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180819

FDA application: NDA019445

## Active ingredients

- DEXTROSE MONOHYDRATE: 250 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1213"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1213
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=73d04839-a2bb-65dd-e053-2991aa0a82ca